STAT

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

The advertisements implore voters to “Reject Big Pharma” — an attempt to turn a public policy debate into a referendum on drug companies’ popularity.
Steven Michaud, president of the Maine Hospital Association, speaks at a news conference with doctors opposed to Question 1, the religious and philosophical exemptions referendum on vaccinations.

The advertisements plastered across city bus stops and flooding television airwaves across Maine make a simple plea to voters: “Reject Big Pharma” by voting yes on a state-wide initiative.

But the referendum that Maine voters will decide on Tuesday, known as Question 1, has little to do with drug prices. Instead, approval would overturn a 2019 law that requires all schoolchildren to receive vaccinations unless granted an exemption by a doctor. The advertisements, meanwhile, are funded in large part not by drug pricing activists but by a nationwide network of anti-vaccine groups.

The media blitz marks a new effort by anti-vaccine activists to win new adherents, and to do so by co-opting public anger toward pharmaceutical companies — not just over exorbitant drug prices but because of the industry’s role in the opioid crisis, which has hit Maine hard.

If the effort to overturn the mandate is successful, public health advocates fear the momentum could bleed across state lines and jeopardize other recent efforts to ban non-medical vaccine exemptions. It would be the first instance in which a state’s effort

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks